The effects of health behaviours and beliefs based on message framing among patients with chronic diseases: a systematic review

ObjectiveThe effectiveness of integrating message framing into educational interventions to promote the health behaviour of patients with chronic diseases is still being debated in nursing research. The objective of this study was to assess the impact of educational interventions based on gain and loss frames on the health behaviours and beliefs of patients with chronic diseases and to identify the frame that achieves better outcomes.DesignThe systematic review was based on PRISMA guidelines for comprehensively searching, appraising and synthesising research evidence.Data sourcesWe searched the PubMed, Web of Science, PsycINFO and CINAHL databases for reports published from database inception until 26 March 2021.Eligibility criteriaIntervention studies, published in English, with adult patients with chronic disease conditions, and with intervention contents involved in the implementation of message framing, were considered. The outcomes were health behaviours or beliefs, such as knowledge, self-efficacy, intention or attitudes.Data extraction and synthesisData extraction and entry were performed using a predesigned data extraction form and assessed independently by two reviewers using the Cochrane Collaboration Risk of Bias I.ResultsA total of 11 intervention studies were included. We found that educational intervention based on both gain and loss frames could enhance the positive effects of communication, and promote healthy behaviours and beliefs in patients with chronic disease. Many of the studies we included here showed the advantage of loss framing messages. Due to the limited number of articles included and without quantitative analysis, this result should be interpreted cautiously.ConclusionsIntegrating message framing into health education might be a promising strategy to motivate patients with chronic disease to improve their health behaviours and beliefs. More extensive and well-designed trials are needed to support the conclusions and discuss the effective framing, moderators and mediators of framing.PROSPERO registration numberCRD42021250931.

The Effect of Malicious Envy on Schadenfreude When Schadenfreude Is Elicited Through Social Comparisons

Previous studies have investigated whether envy, particularly malicious envy, increases feelings of schadenfreude and whether this effect is evident in both gain and loss frames. However, as a social-comparison-based emotion, schadenfreude was not investigated through social comparisons in these previous studies. Thus, the present study aimed to investigate whether malicious envy influences schadenfreude when schadenfreude is elicited in the context of precise and ambiguous social comparisons. To address this issue, participants in the present study were asked to play a monetary game with several other players. In the experimental condition, participants gained less or lost more than the other player; in the control condition, both the participants and the player gained little or lost much. Subsequently, the participants observed that the player encountered a misfortune, that is, gained less or lost more money than the participant. The results showed that when participants knew the exact amount of monetary gained and lost by themselves and the other player (i.e., precise social comparisons), malicious envy increased feelings of schadenfreude only in the loss frame rather than in the gain frame. More importantly, malicious envy turned out to reduce feelings of schadenfreude in both gain and loss frames, when participants did not know the exact amount (i.e., ambiguous social comparisons). The findings provide novel evidence that malicious envy does not always increase schadenfreude particularly when schadenfreude is elicited through social comparisons.

Weight Gain and Loss In Cancer Patients Undergoing Chemotherapy: Importance of Dose Adjustment

Introduction: The established dose of chemotherapy is based on the values of the patient's body weight, where variations during treatment can increase the toxicity of chemotherapy, with the development of nephrotoxicity, among other toxicity profiles, as well as in cases of weight gain, patients may receive low doses and compromise the therapeutic response to the tumor. Objective: to evaluate weight gain and loss in cancer patients undergoing chemotherapy. Methods: Longitudinal analytical study with patients at the end of chemotherapy treatment of both genders. The type, location of the tumor and the antineoplastic agent used were collected from the medical records, as well as height and weight at the beginning of treatment. At the time of collection, anthropometric assessment was performed using body mass index, arm circumference, arm muscle circumference, triceps skinfold thickness and percentage of weight loss. Results: Among the patients included in the study, 47.5% had a weight gain of around 2.5 kg, while the remaining patients (52.5%) had a weight loss of around 2.8 kg. Of the patients who had GFR, 55.5% had severe PP, 33.4% had no significant loss and 11.1 had significant loss. In the current study, only 22% had a GFR <60ml/min/1.73m², but they would already need to readjust the medication calculation. Conclusion: It is important to evaluate body surface variations and also the GFR to adjust the dose of the antineoplastic agent and to prevent or minimize nephrotoxicity, as well as to reduce the risk of underdosing and inefficiency of the therapy.

Non-Hermitian topological states in 2D line-graph lattices: Evolving triple exceptional points on reciprocal line graphs

Non-Hermitian (NH) topological states, such as the doubly-degenerate nodes dubbed as exceptional points (EPs) in Bloch band structure of 2D lattices driven by gain and loss, have attracted much recent interest. We demonstrate theoretically that in the three-site edge-centered lattices, i.e., the so-called line-graph lattices, such as Kagome lattice which is a line graph of hexagonal lattice, there exist three types of triply-degenerate EPs (TEPs) evolving intriguingly on another set of line graphs in the reciprocal space. A single TEP (STEP) with ±1/3 topological charge moves faithfully along the edges of reciprocal line graphs with varying gain and loss, while two STEPs merge distinctively into one unconventional orthogonal double TEP (DTEP) with ±2/3 charge at the vertices, which is characterized with two ordinary self-orthogonal eigenfunctions but one surprising “orthogonal” eigenfunction. Differently, in a modified line-graph lattice with an off-edge-center site, the ordinary coalesced state of DTEPs emerges with three identical self-orthogonal eigenfunctions. Such NH states and their evolution can be generally realized in various artificial systems, such as photonic and sonic crystals, where light and sonic vortex beams with different fractional twisting can be found. Our findings shed new light on fundamental understanding of gapless topological states in NH systems in terms of creation and evolution of high-order EPs, and open up new research directions to further link line graph and flow network theory coupled with topological physics, especially under non-equilibrium gain/loss conditions.

The L1624Q Variant in SCN1A Causes Familial Epilepsy Through a Mixed Gain and Loss of Channel Function

Variants of the SCN1A gene encoding the neuronal voltage-gated sodium channel NaV1.1 cause over 85% of all cases of Dravet syndrome, a severe and often pharmacoresistent epileptic encephalopathy with mostly infantile onset. But with the increased availability of genetic testing for patients with epilepsy, variants in SCN1A have now also been described in a range of other epilepsy phenotypes. The vast majority of these epilepsy-associated variants are de novo, and most are either nonsense variants that truncate the channel or missense variants that are presumed to cause loss of channel function. However, biophysical analysis has revealed a significant subset of missense mutations that result in increased excitability, further complicating approaches to precision pharmacotherapy for patients with SCN1A variants and epilepsy. We describe clinical and biophysical data of a familial SCN1A variant encoding the NaV1.1 L1624Q mutant. This substitution is located on the extracellular linker between S3 and S4 of Domain IV of NaV1.1 and is a rare case of a familial SCN1A variant causing an autosomal dominant frontal lobe epilepsy. We expressed wild-type (WT) and L1642Q channels in CHO cells. Using patch-clamp to characterize channel properties at several temperatures, we show that the L1624Q variant increases persistent current, accelerates fast inactivation onset and decreases current density. While SCN1A-associated epilepsy is typically considered a loss-of-function disease, our results put L1624Q into a growing set of mixed gain and loss-of-function variants in SCN1A responsible for epilepsy.